Cytisinicline

Name: Cytisinicline in Smoking cessation: Access and distribution
Published: 2026-09-14T15:39:06-04:00

Smoking cessation

Manufacturer: Achieve Life Sciences
Regulatory submission: NDA resubmission planned for the fourth quarter of 2026
Launch: Anticipated after potential approval in the first half of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Access and distribution

2 evidence topics · 2 sources

Expanded access

“delivering our investigational therapy to patients through clinical trials” (opens the source at this quote in a new tab)
“does not have an expanded access program” (opens the source at this quote in a new tab)

United Kingdom 1.5 mg tablets: distributor

Distribution role	Quoted organization
Distributor named in the patient leaflet	“Consilient Health Ltd.”